Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
Portfolio Pulse from Avi Kapoor
Jim Cramer discussed several stocks on CNBC's 'Mad Money Lightning Round,' including TORM plc, Trane Technologies, Axsome Therapeutics, and SAP SE. He highlighted TORM's high dividend yield, recommended buying Trane Technologies and SAP, and described Axsome Therapeutics as a high-risk, high-reward stock. Analysts have recently provided ratings and price targets for these companies.
July 24, 2024 | 1:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer describes Axsome Therapeutics as a 'double or nothing' stock due to its focus on CNS breakthroughs. Needham analyst recently initiated coverage with a Buy rating and a $130 price target.
The high-risk, high-reward nature of Axsome Therapeutics, combined with a recent Buy rating and price target from Needham, suggests potential for significant stock price movement.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Jim Cramer recommends buying SAP SE despite its recent earnings miss. He believes the stock has further growth potential.
Despite missing earnings estimates, Cramer's positive outlook and belief in SAP's growth potential suggest a likely short-term increase in the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Jim Cramer recommends buying Trane Technologies ahead of its Q2 earnings report. Analysts expect strong earnings and revenue growth compared to the previous year.
Positive analyst expectations and Cramer's recommendation suggest a potential short-term increase in Trane Technologies' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
TORM plc has a high dividend yield, which supports its stock price. However, Jim Cramer warns that if business conditions worsen, the yield and stock price could decline.
The high dividend yield is currently supporting TORM's stock price, but potential future declines in business conditions could negatively impact the yield and stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80